Skip to main content

UBS Group AG

Position in SGMOQ — Sangamo Therapeutics, Inc

CIK 1610520 ZURICH, V8

Position in SGMOQ

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$642,748
+$212,470 QoQ
Shares Held
2,570,992
+151.0% QoQ
Ownership
0.621%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMOQ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,364,122 across 562 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SGMOQ

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $642,748 2,570,992
2025-12-31 $430,278 1,024,475
2025-09-30 $884,947 1,320,818
2025-06-30 $674,463 1,249,009
2025-03-31 $403,236 610,966
2024-12-31 $340,843 334,161
2024-09-30 $85,406 98,170
2024-06-30 $30,677 85,214
2024-03-31 $107,400 160,300
2023-12-31 $76,780 142,189
2023-09-30 $447,588 745,980
2023-06-30 $125,899 96,847
2023-03-31 $470,998 267,613
2022-12-31 $1,859,048 592,054
2022-09-30 $520,717 106,269
2022-06-30 $818,129 197,616
2022-03-31 $2,674,807 460,380
2021-12-31 $3,063,089 408,412
2021-09-30 $2,611,592 289,855
2021-06-30 $1,379,948 115,284
2021-03-31 $4,331,971 345,728
2020-12-31 $607,026 38,887
2020-09-30 $114,930 12,162
2020-06-30 $1,344,859 150,096
2020-03-31 $151,554 23,792